Company / Debt per Share
TScan Therapeutics, Inc. Debt per Share History
FY2022-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Debt per Share
$0.29
FY2025
5-year range
$0.29 / $2.51
FY2022-FY2025
Trend
-40.6%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Debt per Share has declined for 3 consecutive years, from $2.51 in FY2022 to $0.29 in FY2025.
Based on SEC 10-K filings.
0.29 in FY2025 with a 3-year CAGR of -51.3%.
Improved from $1.11 to $0.29 over the past 2 years.
Debt per Share over time
Growth rates
- 3-Year CAGR
- -51.3%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- TScan Therapeutics, Inc.'s debt per share has declined for 3 consecutive years.
- In FY2025, debt per share decreased 40.6% year-over-year.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -9.69 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.29 | -40.6% |
| FY2024 | $0.49 | -56.0% |
| FY2023 | $1.11 | -55.8% |
| FY2022 | $2.51 | - |
| FY2021 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026